Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 6/20 | 0.38 |
| ▸ | HTR7 | P34969 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7596802 | 0.81 | POLB (0.52) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL20917779 | 0.81 | POLB (0.52) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL4402923 | 0.79 | POLB (0.71) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL931810 | 0.79 | POLB (0.50) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL7532314 | 0.79 | POLB (0.50) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL30341829 | 0.79 | POLB (0.71) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL9715046 | 0.79 | POLB (0.46) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL28751074 | 0.78 | POLB (0.69) | POLBHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL21778844 | 0.78 | F2 (0.50) | POLBKMT2ATSHR | |
| SCHEMBL434649 | 0.76 | POLB (0.52) | POLBHDAC3HDAC4HDAC7HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2258951-B1 | PHOTORESPONSIVE GAS-GENERATING MATERIAL, MICROPUMP AND MICROFLUID DEVICE | SEKISUI CHEMICAL CO LTD (JP) | 2018-08-22 | — | — | EP | claimed |
| WO-2002024693-A1 | A PROCESS FOR PRODUCING 3,4-DIHYDRO NAPHTHYRIDINONE ANALOGS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-28 | — | — | WO | claimed |
| CN-118265709-A | Tetrahydroisoquinoline compounds as KEAP1 binders | 希四克斯探索有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-117836013-A | Radiotracer and therapeutic agents that bind to Fibroblast Activation Protein (FAP) | 蓝地诊断有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-113454058-B | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-115916342-A | Compounds, compositions and methods for treating fibrotic diseases and cancer | 普渡研究基金会 | 2023-04-04 | — | — | CN | disclosed |
| CN-115427044-A | Pyrrolopyrimidines as complement inhibitors | 拜奥克里斯特制药公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-114929675-A | Novel adamantane derivatives as inhibitors of focal adhesion kinase | 三进制药株式会社 | 2022-08-19 | — | — | CN | disclosed |
| CN-110167915-B | Amino-thiol compound, preparation method thereof and application thereof in radiation protection | 上海科州药物研发有限公司 | 2021-11-26 | — | — | CN | disclosed |
| EP-3452465-B1 | SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES | GENOSCIENCE PHARMA (FR) | 2020-11-04 | — | — | EP | disclosed |
| US-10577362-B2 | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases | GENOSCIENCE PHARMA (FR) | 2020-03-03 | — | — | US | disclosed |
| CN-101679829-A | Photocurable adhesive composition | SEKISUI CHEMICAL CO LTD | 2010-03-24 | — | — | CN | disclosed |
| US-20090202942-A1 | PROCESS FOR PRODUCING PATTERNED FILM AND PHOTOSENSITIVE RESIN COMPOSITION | SEKISUI CHEMICAL CO., LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-7396936-B1 | Modulators of calcitonin and amylin receptor activity | KEMIA, INC. (US) | 2008-07-08 | — | — | US | disclosed |
| US-7041674-B2 | Carbamic acid esters with anticholinergic activity | BOEHRINGER INGELHIEM PHARMA GMBH & CO. KG (DE) | 2006-05-09 | — | — | US | disclosed |
| US-20040132760-A1 | Carbamic acid esters with anticholinergic activity | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-07-08 | — | — | US | disclosed |
| CN-1443179-A | Aniline derivatives | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | CN | disclosed |
| WO-2002024693-A1 | A PROCESS FOR PRODUCING 3,4-DIHYDRO NAPHTHYRIDINONE ANALOGS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-28 | — | — | WO | disclosed |
| CN-1164237-A | New peptides with immunomodulatory effects | ASTRA AB (SE) | 1997-11-05 | — | — | CN | disclosed |
| EP-0608198-A1 | Cyclic diphenylacetonenitriles as stabilisers | CIBA-GEIGY AG (CH) | 1994-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10577362-B2 | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases | NQO2, RECQL, CCNO | POLB 515/4885HDAC3 4144/4885HDAC4 2839/4885 |
| US-20040132760-A1 | Carbamic acid esters with anticholinergic activity | CHRM2, CHRM1, ACHE | POLB 4105/4885HDAC3 521/4885HDAC4 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.